Global gene expression profile of Saccharomyces cerevisiae induced by dictamnine

Yeast

Volumn 25, Issue 9, 2008, Pages 631-641

  Guo, Na ^a   Yu, Lu ^a   Meng, Rizeng ^b   Fan, Junwen ^a   Wang, Dacheng ^a   Sun, Guang ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b Jilin Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Dictamnine; Oligonucleotide microarray; Phenotype; Saccharomyces cerevisiae; Transcription

Indexed keywords

DICTAMNINE; LIPID; RIBOSOME RNA; RNA POLYMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MSN2P; TRANSCRIPTION FACTOR MSN4P; UNCLASSIFIED DRUG;

ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EXPOSURE; DRUG STRUCTURE; ENVIRONMENTAL STRESS; FUNGAL STRAIN; FUNGUS GROWTH; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; LIPOGENESIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE;

GENE EXPRESSION PROFILING; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, FUNGAL; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 53349090516     PISSN: 0749503X     EISSN: 10970061     Source Type: Journal    
DOI: 10.1002/yea.1614     Document Type: Article

References (52)

1. Agarwal AK, Rogers PD, Baerson SR, et al. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 278: 34998-35015.
2. Ashburner M, Ball CA, Blake JA, et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 1: 25-29.
3. Ashwood-Smith MJ, Towers GH, Abramowski Z, Poulton GA, Liu M. 1982. Photobiological studies with dictamnine, a furoquinoline alkaloid. Mutat Res 102: 401-412.
4. Balzi E, Goffeau A. 1995. Yeast multidrug resistance: the PDR network. J Bioenerg Biomembr 27: 71-76.
5. Bammert GF, Fostel JM. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 44: 1255-1265.
6. Boorsma A, Foat BC, Vis D, et al. 2005. T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Res 33: W592-595.
7. Borchardt JK. 2003. Traditional Chinese drug therapy. Drug New Perspect 16: 698-702.
8. Cavalieri D, Townsend JP, Hartl DL. 2000. Manifold anomalies in gene expression in a vineyard isolate of Saccharomyces cerevisiae revealed by DNA microarray analysis. Proc Natl Acad Sci USA 97: 12369-12374.
9. Collart MA, Oliviero S. 1995. Preparation of yeast RNA. In Short Protocols in Molecular Biology, 3rd edn, Ausubel F, Brent R, Kingston RT, et al. (eds). Wiley: New York; 13-46-13-47.
10. Decottignies A, Grant AM, Nichols JW, et al. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 273: 12612-12622.
11. El Sayed K, Al-Said MS, El-Feraly FS, Ross SA. 2000. New quinoline alkaloids from Ruta chalepensis. J Nat Prod 63: 995-997.
12. Fan X, Shi H, Lis JT. 2005. Distinct transcriptional responses of RNA polymerases I, II and III to aptamers that bind TBP. Nucleic Acids Res 33(3): 838-845.
13. Fishman-Lobell J, Rudin N, Haber JE. 1992. Two alternative pathways of double-strand break repair that are kinetically separable and independently modulated. Mol Cell Biol 12: 1292-1303.
14. Gasch A. P. 2003. The environmental stress response: a common yeast response to diverse environmental stresses. Curr Top Genet 1: 11-70.
15. Gasch AP, Spellman PT, Kao CM, et al. 2000. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11: 4241-4257.
16. Goffeau A. 2000. Four years of post-genomic life with 6000 yeast genes. FEBS Lett 480: 37-41.
17. Grivell LA. 1995. Nucleo-mitochondrial interactions in mitochondrial gene expression. Crit Rev Biochem Mol Biol 30: 121-164.
18. Groll AH, Piscitelli SC, Walsh TJ. 1998. Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Adv Pharmacol 44: 343-500.
19. Guo Y, Guo H, Zhang L, et al. 2005. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol 79: 14392-14403.
20. Huisinga KL, Pugh BF. 2004. A genome-wide housekeeping role for TFIID and a highly regulated stress-related role for SAGA in Saccharomyces cerevisiae. Mol Cell 13: 573-585.
21. Jazwinski SM. 2002. Growing old: metabolic control and yeast aging. Annu Rev Microbiol 56: 769-792.
22. Katzmann DJ, Burnett PE, Golin J, et al. 1994. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol Cell Biol 14: 4653-4661.
23. Lester RL, Dickson RC. 1993. Sphingolipids with inositolphosphate-containing head groups. Adv Lipid. Res 26: 253-274.
24. Liu ZL, Xu YJ, Wu J, et al. 2002. Feeding deterrents from Dictamnus dasycarpus Turcz against two stored-product insects. J Agric Food Chem 50: 1447-1450.
25. Lu L, Roberts G, Simon K, et al. 2003. Rsf1p, a protein required for respiratory growth of Saccharomyces cerevisiae. Curr Genet 43: 263-272.
26. Mahé Y, Parle-McDermott A, Nourani A, et al. 1996. The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Mol Microbiol 20: 109-117.
27. Mao C, Wadleigh M, Jenkins GM, et al. 1997. Identification and characterization of Saccharomyces cerevisiae dihydrosphingosine-1-phosphate phosphatase. J Biol Chem 272: 28690-28694.
28. Mitchell AG, Martin CE. 1997. Fah1p, a Saccharomyces cerevisiae cytochrome b5 fusion protein, and its Arabidopsis thaliana homolog that lacks the cytochrome b5 domain both function in the α-hydroxylation of sphingolipid-associated very long chain fatty acids. J Biol Chem 272: 28281-28288.
29. Motulsky H. 1995. Intuitive Biostatistics. Oxford University Press: New York.
30. Murata Y, Watanabe T, Sato M, et al. 2003. Dimethyl sulphoxide exposure facilitates phospholipid biosynthesis and cellular membrane proliferation in yeast cells. J Biol Chem 278: 33185-33193.
31. Myers AM, Pape LK, Tzagoloff A. 1985. Mitochondrial protein synthesis is required for maintenance of intact mitochondrial genomes in Saccharomyces cerevisiae. EMBO J 4: 2087-2092.
32. Nagiec MM, Nagiec EE, Baltisberger JA, et al. 1997. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem 272: 9809-9817.
33. Nakamura K, Niimi M, Niimi K, et al. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother 45: 3366-3374.
34. National Committee for Clinical Laboratory Standards. 1997. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Proposed Standard M27-A. National Committee for Clinical Laboratory Standards (NCCLS): Villanova, PA.
35. Ng WL, Kazmierczak KM, Robertson GT, et al. 2003. Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors. J Bacteriol 185: 359-370.
36. Owsianik G, Balzi I L, Ghislain M. 2002. Control of 26S proteasome expression by transcription factors regulating multidrug resistance in Saccharomyces cerevisiae, Mol Microbiol 43: 1295-1308.
37. Parveen M, Hasan MK, Takahashi J, et al. 2004. Response of Saccharomyces cerevisiae to a monoterpene: evaluation of antifungal potential by DNA microarray analysis. J Antimicrob Chemother 54: 46-55.
38. Paulini H, Eilert1 U, Schimmer O. 1987. Mutagenic compounds in an extract from Rutae Herba (Ruta graveolens L.) I. Mutagenicity is partially caused by furoquinoline alkaloids. Mutagenesis 2: 271-273.
39. Paulsen IT, Brown MH, Skurray RA. 1996. Proton-dependent multidrug efflux systems. Microbiol Rev 60: 575-608.
40. Pfyffer GE, Towers GH. 1982. Photochemical interaction of dictamnine, a furoquinoline alkaloid, with fungal DNA in vitro and in vivo. Can J Microbiol 28: 468-473.
41. Satoh H, Delbridge LM, Blatter LA, et al. 1996. Surface: volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects. Biophys J 70: 1494-1504.
42. Shianna KV, Dotson WD, Tove S, Parks LW. 2001. Identification of a UPC2 homolog in Saccharomyces cerevisiae and its involvement in aerobic sterol uptake. J Bacteriol 183: 830-834.
43. Van den Bosch M, Lohman PH, Pastink A. 2002. DNA double-strand break repair by homologous recombination. Biol Chem 383: 873-892.
44. Vik A, Rine J. 2001. Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae. Mol Cell Biol 19: 6395-6405.
45. Wang LD, Guo DA, Yuan L, et al. 2000. Antifungal effect of three natural products on the genetic substance of Saccharomyces scerevisiae GL7 and Prototheca wickerhamii. Yao Xue Xue Bao 35: 860-863.
46. Wu TS, Wang ML, Shyur HJ, et al. 1994. Chemical constituents and bioactive principles from the root bark of Dictamnus dasycarpus. J Chin Pharm 46: 447-455.
47. Yang YH, Dudoit S, Luu P, et al. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15.
48. Yu L, Zhang W, Wang L, et al. 2007. Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum. Antimicrob Agents Chemother 51: 144-153.
49. Zhao W, Wolfender JL, Hostettmann K, et al. 1998. Antifungal alkaloids and limonoid derivatives from Dictamnus dasycarpus. Phytochemistry 47: 7-11.
50. Zakrzewska A, Boorsma A, Brul S, et al. 2005. Transcriptional response of Saccharomyces cerevisiae to the plasma membrane-perturbing compound chitosan. Eukaryot Cell 4: 703-715.
51. Zakrzewska A, Boorsma A, Delneri D, et al. 2007. Cellular processes and pathways that protect Saccharomyces cerevisiae cells against the plasma membrane-perturbing compound chitosan. Eukaryot Cell 6: 600-608.
52. Zhang L, Zhang Y, Zhou Y, et al. 2002. Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J Antimicrob Chemother 49: 905-915.